If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: asthma. This novel therapeutic ...

BOULDER, Colo.--(BUSINESS WIRE)--#AI--Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: ...

Figuring out how your genes and environment increase your likelihood of developing asthma ... these differences in drug effects between patients? Is it their genes? Are they not taking their ...

an innovative biologic therapy for asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). This acceptance, announced today, is based on the promising results from the SWIFT and ANCHOR ...

Your physical environment, social life and lifestyle have as much an influence on your biology − and hence, how you process drugs − as your genes.

Propolis is a mixture of pollen and beeswax produced by honey bees. It contains flavonoids and has antioxidant, antimicrobial, and anti-inflammatory properties. Propolis has a long history of use as a ...

Aiming to describe the characteristics and the course of clinical remission with omalizumab therapy discontinuation, we contacted patients from a previous cohort of Brazilian pediatric patients with ...